What really matters with thrombocytopenia: absolute value, timing, etiology or management? Author's reply

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

  • Carl Thomas Anthon
  • Frédéric Pène
  • Sanjay Chawla
  • Kathryn Puxty
  • Russell, Lene
Thrombocytopenia in the intensive care unit (ICU) is a complex condition with diverse contributing factors often concurrently present. While associated with worse outcomes [2, 3], the extent to which underlying cause(s), disease severity, or thrombocytopenia itself impacts prognosis is uncertain and likely varies between subpopulations. Although we agree that the aetiology, mechanisms and subsequent management of thrombocytopenia are important, this was not the focus of the PLOT-ICU study, and we did not collect data on presumed or confirmed causes of thrombocytopenia besides underlying comorbid conditions. This would have required a different setup, including a systematic and comprehensive diagnostic workup of patients with thrombocytopenia and a considerably larger sample size.
OriginalsprogEngelsk
TidsskriftIntensive Care Medicine
Vol/bind50
Udgave nummer2
Sider (fra-til)306-307
Antal sider2
ISSN0342-4642
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
The Department of Intensive Care at Rigshospitalet (CTA) has received funding for other projects from the Novo Nordisk Foundation, Sygeforsikringen ‘danmark’, and Pfizer and has conducted contract research for AM‑Pharma. FP has received honoraria for consulting and lectures from Gilead and an institutional grant from Alexion Pharma. SC, KP and LR have no conflict of interest to declare.

ID: 379707130